Patents, brand-generic competition and the pricing of ethical drugs in Canada: some empirical evidence from British Columbia, 1981-1994

References

• Anis , A. H. 1992 . Pharmaceutical prices with insurance coverage and formularies . Canadian Journal of Economics , XXV ( 2 ) : 420 – 437 .
   Web of Science ®Google Scholar
• Bresnahan , T. F. 1989 . “ Empirical studies of industries with market power ” . In Handbook of Industrial Organization , Edited by: Schmalensee , R. and Willig , R. D. New York : North-Holland . chapter 7
   Google Scholar
• British Columba . 1993 . Ministry of Health and Ministry responsible for Seniors , Victoria, BC : Shaping the Future of Pharmacare .
   Google Scholar
• Canada . 1963 . “ Restrictive Trade Practices Commission ” . In Report Concerning the Manufacture, Distribution and Sale of Drugs , Ottawa : Queen's Printer .
   Google Scholar
• Canada . 1964 . Royal Commission on Health Care Report , Ottawa : Emmett Hall Commissioner, Queen's Printer .
   Google Scholar
• Canada . 1967 . “ House of Commons ” . In Second (Final) Report of the Special Committee of the House of Commons on Drug Costs, and Prices , Ottawa : Queen's Printer .
   Google Scholar
• Canada . 1985a . The Report of the Commission of Inquiry on the Pharmaceutical Industry , Ottawa : Harry C. Eastman: Commissioner, Ministry of Supply and Services .
   Google Scholar
• Canada . 1985b . The Report of the Commission of Inquiry on the Pharmaceutical Industry: A Summary , Ottawa : Ministry of Supply and Services .
   Google Scholar
• Canada . 1992 . Patent Medicine Prices Review Board, Fourth Annual Report for the Year Ending 31 December 1991 , Ottawa : Minister of Supply and Services Canada .
   Google Scholar
• Canada . 1994 . National Health Expenditures in Canada, 1985–1993 , Ottawa : Health Canada .
   Google Scholar
• Caves , R. E. , Whinston , M. D. and Hurwitz , M. A. 1991 . Patent expiration, entry and competition in the US Pharmaceutical Industry . Brookings Papers on Economic Activity , : 1 – 48 .
   Web of Science ®Google Scholar
• Comanor , W. S. and Schweitzer , S. O. 1995 . “ Pharmaceuticals ” . In The Structure of American Industry , Ninth Edn Edited by: Adams , W. and Barek , J. 177 – 196 . Englewood Cliffs, New Jersey
   Google Scholar
• Eastman , H. C. 10 June 1993 . Notes for an address before the Pharmacare Panel to Review the BC drug plan 10 June , Vancouver, BC mimeo
   Google Scholar
• Frank , R. G. and Salever , D. 1992 . Pricing, patent loss and the market for pharmaceuticals . Southern Economic Journal , 59 October : 165 – 179 .
   Web of Science ®Google Scholar
• Gorecki , P. K. 1981 . Regulating the Price of Prescription Drugs in Canada: Compulsory Licensing, Product Selection, and Government Reimbursement Programmes , Ottawa : Economic Council of Canada .
   Google Scholar
• Gorecki , P. K. 1986 . The importance of being first: the case of prescription drugs in Canada . International Journal of Industrial Organization , 4 : 371 – 395 .
   Google Scholar
• Gorecki , P. K. 1993 . A comparison of two drug reimbursement pricing models: BC Pharmacare and the Ontario drug benefit programme . Canadian Journal of Economics , XXVI ( 2 ) : 867 – 877 .
   Web of Science ®Google Scholar
• Grabowski , H. G. and Vernon , J. M. 1992 . Brand loyalty, entry, and price competition in pharmaceuticals after the 1984 Drug Act . The Journal of Law and Economics , 35 : 331 – 350 .
   Web of Science ®Google Scholar
• Lexchin , J. 1993 . Pharmaceuticals, patents, and politics: Canada and Bill C-22 . International Journal of Health Services , 23 ( 1 ) : 147 – 160 .
   PubMed Web of Science ®Google Scholar
• McRae , J. J. and Tapon , F. 1985 . Some empirical evidence on post-patent barriers to entry in the Canadian pharmaceutical industry . Journal of Health Economics , 4 : 43 – 61 .
   PubMed Web of Science ®Google Scholar
• Robinson , W. T. , Kalyanaran , G. and Urban , G. L. 1994 . First mover advantages from pioneering new markets: a survey of empirical evidence . Review of Industrial Organization , 9 ( 1 ) : 1 – 23 .
   Google Scholar
• Scherer , F. M. 1996 . Industry Structure, Strategy and Public Policy , New York : HarperCollins .
   Google Scholar
• SCRIP . 17 Feb. 1995 . World Pharmaceutical News 2000 17 Feb. , 20
   Google Scholar
• Spurgeon , D. 1993 . Supreme Court decision may have major impact on drug industry . Canadian Medical Association Journal , 148 : 629 – 631 .
   Web of Science ®Google Scholar